Skip to Content
Cancer Therapy Evaluation Program (CTEP)


Office of the Associate Director
Plans, evaluates and coordinates extramural clinical research programs testing combined modality approaches and the testing of investigational new agents
Clinical Grants and Contracts Branch
Funds investigator-initiated clinical research
Clinical Investigations Branch
Oversees late phase, multi-center clinical trials exploring new therapeutics and biomarkers
Clinical Trials Monitoring Branch
Ensures data integrity and compliance with protocol and regulatory requirements
Clinical Trials Operations and
Informatics Branch

Supports IT and other key aspects of protocol development, review, and conduct
Investigational Drug Branch
Implements clinical trials of experimental therapeutics
Pharmaceutical Management Branch
Delivers pharmaceutical support and registers investigators for NCI clinical trials
Regulatory Affairs Branch
Provides IND support and implements agreements  for pharmaceutical use

Message from the Associate Director

Jeffrey S. Abrams, M.D.The Cancer Therapy Evaluation Program (CTEP) coordinates the clinical therapeutics development program of the Division of Cancer Treatment and Diagnosis (DCTD).

Fueled by our improved understanding of the human genome, CTEP leads NCI's effort to conduct innovative precision medicine treatment trials. More...

Research Spotlights

Other CTEP-Related Initiatives